Patel Kavina, Liu Lucy, Ahn Benjamin, Silfvast-Kaiser Annika S, Paek So Yeon
Long School of Medicine, University of Texas Health San Antonio, San Antonio, Texas.
University of Washington School of Medicine, Seattle, Washington.
Proc (Bayl Univ Med Cent). 2020 Jul 27;33(4):586-591. doi: 10.1080/08998280.2020.1793643.
Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin condition resulting in the formation of nodules, sinus tracts, and abscesses typically in intertriginous regions. HS management is often difficult and involves a multimodal approach, evaluating the benefit of both medical and surgical treatment options, along with treating associated pain and medical comorbidities that present concomitantly with the disease. In this article, we synthesize for the nondermatology clinician the evidence for various HS treatments, along with the diagnostic and therapeutic guidelines for HS published by the British Association of Dermatologists, US and Canadian HS Foundations, HS ALLIANCE, Canadian Dermatology Association, and Brazilian Society of Dermatology. Management of HS requires an individualized, patient-centered approach due to the lack of rigorous evidence for many interventions.
化脓性汗腺炎（HS）是一种慢性复发性炎症性皮肤病，通常在皮肤褶皱部位形成结节、窦道和脓肿。HS的治疗往往很困难，需要采取多模式方法，评估药物和手术治疗方案的益处，同时治疗与该疾病同时出现的相关疼痛和合并症。在本文中，我们为非皮肤科临床医生综合了各种HS治疗方法的证据，以及英国皮肤科医师协会、美国和加拿大HS基金会、HS联盟、加拿大皮肤科协会和巴西皮肤科协会发布的HS诊断和治疗指南。由于许多干预措施缺乏严格的证据，HS的管理需要一种个性化的、以患者为中心的方法。
